0.0001USD0.00%Mkt Cap: 1584 USDP/E: —Last update: 2026-05-25
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics in the United States, China, the United Arab Emirates, V…
Industry Peers
Medical Devices151.38BUSDP/E 24.3
119.84BUSDP/E 36.2
86.12BUSDP/E 24.2
53.79BSEKP/E 100.1
52.47BSEKP/E 22.3
51.50BDKKP/E 21.8
50.54BUSDP/E 47.4
38.75BEURP/E 18.3
Indicators:|
Key Statistics
Company
Market Cap1.58K USD
Enterprise Value4.33M USD
Revenue (TTM)9.61M USD
Gross Profit1.93M USD
Net Income (TTM)-17.98M USD
Revenue/Share3.138 USD
Last Price0.0001 USD
Fiscal Year EndDec 2023
MR QuarterMar 2024
Employees25
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)0.00
PEG1.86
EV/EBITDA-0.89
EV/Revenue0.45
P/S0.00
P/B0.00
EPS (TTM)-3.98
EPS (Forward)0.20
52W Range
—
52W High0.0001 USD
52W Low0.0001 USD
Profitability
Gross Margin20.44%
Oper. Margin-20.35%
EBITDA Margin-50.70%
Profit Margin-190.31%
ROE1078.28%
ROA-160.03%
Growth
Revenue Growth6.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.72M USD
CapEx (TTM)1.73M USD
FCF Margin-0.71%
FCF Yield-4285.04%
Net Debt6.39M USD
Net Debt/EBITDA-1.31
Balance Sheet
Debt/Equity-6.33
Current Ratio0.52
Quick Ratio0.28
Book Value/Sh0.1230 USD
Cash/Share0.1480 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJun 5, 2019
Splits
Last Split1:45
Split DateDec 22, 2022
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.15.85M
Float1.76M
Insiders0.00%
Institutions0.00%
Short Interest
Short Ratio1.4d
Short % Float0.30%
Short % Out.0.27%
Shares Short21.34K
Short (prev mo.)52.98K
Technical
SMA 500.0001 (-0.0%)
SMA 2000.0001 (-0.0%)
Beta15.83
S&P 52W Chg28.31%
Avg Vol (30d)131
Avg Vol (10d)148
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—